Fabrication of Size-Controlled Carbon Dots with Biofilm-Disrupting Activity for Antibacterial Applications
International Journal of Molecular Sciences · 07.05.2026 · 27 (10) · 4159
DOI: 10.3390/ijms27104159 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.05.2026. Verfasst von Yu-Xin Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550014, China. Hauptthemen laut MEDLINE: Carbon Quantum Dots, Anti-Bacterial Agents, Biofilms, Carbon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation-Key Research Project of the Daxing, China Postdoctoral Science Foundation, Guizhou Science and Technology Cooperation Foundation.
Abstract (Originalsprache)
Carbon dots (CDs) have demonstrated broad-spectrum biological activity, with particle size considered a key determinant of their biological efficacy. However, the interrelationships among size, structure, and function remain unclear. To address this, we synthesized CDs under identical hydrothermal protocols and separated them into four size fractions (NPDCDs1-NPDCDs4), to directly investigate how particle size influences physicochemical and antibacterial properties. The four fractions exhibited distinct optical and structural properties: NPDCDs1 (3.2 nm) emitted at 510 nm with the highest C-O content; NPDCDs2 (2.2 nm) emitted at 510 nm with high C-C/C=C content; NPDCDs3 (2.1 nm) showed red-shifted emission at 570 nm and the highest C=C ratio; NPDCDs4 (1.9 nm) displayed the most red-shifted emission at 580 nm (λex = 380 nm) with the highest C=O content. Notably, NPDCDs1 demonstrated excellent biocompatibility and potent antibacterial activity, primarily through efficient disruption of bacterial biofilms, possibly due to its high C-O content and appropriate particle size. Thus, particle size modulated biological function via corresponding changes in structural and surface chemical properties. These findings clarify that particle size critically influences both the physicochemical properties and antibacterial activity of CDs, providing an empirical foundation for the rational design of highly efficient and low-toxicity carbon-based antimicrobial materials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550014, China.
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
- Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Förderung
- Beijing Municipal Natural Science Foundation-Key Research Project of the Daxing
- China Postdoctoral Science Foundation
- Guizhou Science and Technology Cooperation Foundation
- Joint Research Project of the Shijiazhuang-Peking University Cooperation Program
Zitieren
APA
Qian, Y. X., Yu, M., Chen, Z. K., Shen, Y., Tang, L., Zeng, K. W., & Tu, P. F. (2026). Fabrication of Size-Controlled Carbon Dots with Biofilm-Disrupting Activity for Antibacterial Applications. International Journal of Molecular Sciences, 27(10), 4159. https://doi.org/10.3390/ijms27104159
Vancouver
Qian YX, Yu M, Chen ZK, Shen Y, Tang L, Zeng KW, et al. Fabrication of Size-Controlled Carbon Dots with Biofilm-Disrupting Activity for Antibacterial Applications. International Journal of Molecular Sciences. 2026;27(10):4159. doi:10.3390/ijms27104159
BibTeX
@article{Qian2026,
author = {Qian, Yu-Xin and Yu, Ming and Chen, Ze-Kun and Shen, Yue and Tang, Lei and Zeng, Ke-Wu and Tu, Peng-Fei},
title = {Fabrication of Size-Controlled Carbon Dots with Biofilm-Disrupting Activity for Antibacterial Applications},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4159},
doi = {10.3390/ijms27104159}
}
EUVIMED